Standout Papers
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases (2007)
- Treatment of Multidrug-Resistant Tuberculosis (1993)
- Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin (1993)
- The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis (2005)
Immediate Impact
2 by Nobel laureates 27 from Science/Nature 62 standout
Citing Papers
Engineering bacteria as interactive cancer therapies
2022 StandoutScience
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Works of Michael D. Iseman being referenced
The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis
2005 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael D. Iseman | 5490 | 6565 | 2235 | 2316 | 69 | 8.9k | |
| Fred M. Gordin | 6291 | 6869 | 2043 | 2038 | 79 | 9.2k | |
| Antonino Catanzaro | 6930 | 8007 | 1807 | 2386 | 136 | 10.3k | |
| Stephen J. Ruoss | 3326 | 4620 | 1382 | 2225 | 61 | 7.1k | |
| C. Fordham von Reyn | 6347 | 7719 | 2163 | 2479 | 125 | 9.8k | |
| Timothy R. Aksamit | 3596 | 5170 | 1158 | 2301 | 83 | 6.7k | |
| Kenneth N. Olivier | 6073 | 8798 | 1662 | 4165 | 129 | 12.0k | |
| Jakko van Ingen | 5581 | 6602 | 1231 | 2722 | 231 | 8.0k | |
| Gwen A. Huitt | 3868 | 5481 | 1127 | 2852 | 28 | 6.2k | |
| David E. Griffith | 6984 | 9493 | 1720 | 4608 | 157 | 11.8k | |
| William E. Dismukes | 12010 | 12796 | 1094 | 1111 | 100 | 16.2k |
All Works
Loading papers...